ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,791Medicare Part D Prescriptions Filled, Including Refills

Rank: 162 out of 1383

$865K Total Retail Price of All Prescriptions

Rank: 87 out of 1383

482 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
45% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 482 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

17% of this provider’s 482 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 12,033 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 492 382 S3 1 1
LISINOPRIL 427 351 2 3
FUROSEMIDE 373 355 3 7
LEVOTHYROXINE SODIUM 360 325 4 4
CITALOPRAM HBR 345 318 5 15
OMEPRAZOLE 321 264 6 5
METOPROLOL TARTRATE 315 281 7 9
SIMVASTATIN 292 268 8 2
GABAPENTIN 258 206 9 11
ATORVASTATIN CALCIUM 252 239 10 18
POTASSIUM CHLORIDE 244 230 11 12
AMLODIPINE BESYLATE 242 229 12 6
CRESTOR 238 180 13 34
FAMOTIDINE 222 219 14 61
TRAMADOL HCL 219 201 15 25
TRAZODONE HCL 179 135 16 36
ALLOPURINOL 169 157 17 33
PRAVASTATIN SODIUM 169 152 17 14
PREDNISONE 165 156 19 40
LOVASTATIN 150 147 20 22
ALENDRONATE SODIUM 148 135 21 37
METOPROLOL SUCCINATE 143 122 22 29
CARVEDILOL 139 137 23 24
IPRATROPIUM BROMIDE 133 90 24 174
METFORMIN HCL 132 114 25 8
NIASPAN 132 132 25 148
LISINOPRIL-HYDROCHLOROTHIAZIDE 127 113 27 27
DONEPEZIL HCL 118 118 28 35
ALBUTEROL SULFATE 117 78 29 124
MIRTAZAPINE 116 110 30 51
LOSARTAN POTASSIUM 109 95 31 23
RANITIDINE HCL 99 66 32 19
LANTUS 99 84 32 50
MELOXICAM 99 91 32 20
IPRATROPIUM-ALBUTEROL 96 90 35 138
BETASERON 96 96 35 386
NAMENDA 92 92 37 49
WARFARIN SODIUM 91 91 38 13
METFORMIN HCL ER 87 68 39 47
SYNTHROID 87 75 39 73
DIGOXIN 83 79 41 59
CLOPIDOGREL 81 77 42 28
ATENOLOL 81 75 42 16
PLAVIX 81 81 42 43
FLUTICASONE PROPIONATE 81 71 42 39
TAMSULOSIN HCL 80 64 46 30
GLIMEPIRIDE 79 69 47 31
PANTOPRAZOLE SODIUM 78 72 48 32
HYDROCHLOROTHIAZIDE 75 63 49 10
LEVOFLOXACIN 75 69 49 88
VENLAFAXINE HCL ER 74 74 51 102
NEXIUM 73 63 52 26
CARBIDOPA-LEVODOPA 70 65 53 108
FINASTERIDE 68 65 54 121
ZOLPIDEM TARTRATE 67 44 55 17
SERTRALINE HCL 66 53 56 21
SPIRIVA 64 52 57 45
FENTANYL 61 40 S2 58 92
CLONIDINE HCL 57 51 59 44
OXYCODONE-ACETAMINOPHEN 55 46 S2 60 107
SULFAMETHOXAZOLE-TRIMETHOPRIM 54 46 61 89
KLOR-CON M20 54 54 61 100
TRIAMTERENE-HCTZ 54 54 61 48
HYDROMORPHONE HCL 50 50 S2 64 298
HYDRALAZINE HCL 50 44 64 86
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 19, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.